Treatment with the antagonist seemed to have a stronger effect on phagocytosis than C3aR deletion at 60 min post-infection, which may reflect the difference in the dynamic range of the assay due to the use of a higher MOI in the antagonist experiment. The gene discussed is C3AR1; the disease is infection.